Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Bejo Zaden B V has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 4 distinct examiners, meaning that every pending matter is being reviewed by a different individual. The prosecution activity is concentrated within 2 distinct art units, which suggests the technical content remains within a relatively narrow field.
DEVEAU ROSEN, JASON is the busiest examiner, currently managing 1 busiest examiner pending action. This distribution shows that no single examiner is handling more than one of the 4 pending office actions for the company. The involvement of 4 distinct examiners across 2 distinct art units suggests a variety of examiner perspectives even within a small number of pending matters. Practitioners must be prepared to navigate the specific preferences of four different examiners while operating within a limited number of technical classifications. The absence of any examiner overlap indicates that each application is being evaluated as an independent matter without a central point of contact in the examination corps. This decentralized approach at the examiner level is contrasted by the focus on only 2 distinct art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DEVEAU ROSEN, JASON | 1 | 80.0% | +16.3% |
| CHATTERJEE, JAYANTA | 1 | 44.0% | +70.1% |
| COLLINS, CYNTHIA E | 1 | 82.2% | +9.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19480694 | Brussels Sprouts, Headed Cabbage, Cauliflower and Kale Plants with a Non-Bitter Taste | DEVEAU ROSEN, JASON | — |
| 18841923 | Brassica Oleracea Plants Resistant to Diamondback Moth | COLLINS, CYNTHIA E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19480694 | Brussels Sprouts, Headed Cabbage, Cauliflower and Kale Plants with a Non-Bitter Taste | DEVEAU ROSEN, JASON | — |
| 18869959 | Anthocyanin-Free Broccoli | CHATTERJEE, JAYANTA | — |
| Art Unit | Apps |
|---|---|
| 1662 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19480694 | Brussels Sprouts, Headed Cabbage, Cauliflower and Kale Plants with a Non-Bitter Taste | DEVEAU ROSEN, JASON | 1662 | §102§103§112 | Non-Final OA | — | Pending | Oct 31, 2025 |
| 18869959 | Anthocyanin-Free Broccoli | CHATTERJEE, JAYANTA | 1662 | §103 | Final Rejection | — | Pending | Nov 27, 2024 |
| 18841923 | Brassica Oleracea Plants Resistant to Diamondback Moth | COLLINS, CYNTHIA E | 1662 | §102§112 | Non-Final OA | — | Pending | Aug 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBejo Zaden B V has 3 pending office actions as of October 2026, spread across 1 art units and 3 examiners.
Jason Deveau Rosen has the most, with 1 of Bejo Zaden B V's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
